Poolbeg Pharma "really open" to different types of deal for POLB 001 | News Direct

Poolbeg Pharma "really open" to different types of deal for POLB 001

Poolbeg Pharma PLC
News release by Poolbeg Pharma PLC

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | March 01, 2023 03:40 AM Eastern Standard Time

 

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) VP of Business Development David English speaks to Proactive's Thomas Warner about the work he's doing to progress the clinical stage infectious disease pharmaceutical company's lead asset POLB 001.

 

English says that Poolbeg is "in a good position" for partnering in general, adding that the company is "really open" to different types of deals for lead asset POLB 001.

 

 

Contact Details

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

project media

Tags

HealthPharmaceuticalOncologyInfectious Disease